Cimarron Medical is a biopharmaceutical company developing treatments for pancreatic cancer.
Industry
Sector :
Subsector :
founded date
01.01.1995
Company Type
For Profit
IPO status
Private
Description
Cimarron Medical is focused on developing SBP-101, a proprietary polyamine for the treatment of pancreatic cancer and pancreatitis. Additionally, the company offers Laboratory Workflow Systems through its subsidiary, Cimarron Medical Software, Inc., which provides essential capabilities for data factories in the life sciences markets, including information modeling, sample tracking, workflow, and reporting.